Potential for Anti-Chagas Therapies Using Structure-based Drug Design

News   Sep 27, 2017 | Original story from Tokyo Institute of Technology

 
Potential for Anti-Chagas Therapies Using Structure-based Drug Design

Results of the TcSpdSyn-ligand docking analysis. Docking poses of the top five compounds (green: docking results, pink: dcSAM). This simulation was conducted with the TcSpdSyn X-ray structure (PDB ID code: 3BWC). The docking results show that all compounds bind to the putrescine-binding site and that dcSAM binding in its own site. Credit: Yoshino, R. et al. Sci Rep. (2017). doi:10.1038/s41598-017-06411-9

 
 
 

RELATED ARTICLES

Towards Personalized Medicine: One Type of Data is Not Enough

News

To understand the biology of diseased organs researchers use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalized treatment.

READ MORE

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.

READ MORE

Simple Sugar Prevents Neurodegeneration in Lysosomal Storage Disease

News

New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy